Cover Story

Ethix Pharma: Strengthening Medico-Regulatory Services across the Country

The global medico-regulatory affairs outsourcing market was valued at $ 1.9 billion in 2014 and is expected to reach $ 5.7 billion by 2023, at a CAGR of 11.5 percent during the forecast period from 2015 to 2023 (Source - Transparency Market Research forecast 2015-2023). In recent years innovator companies are increasingly relying on the CROs not only for clinical trials but for other specialized activities in drug development process. Biopharmaceutical companies are now outsourcing their medico-regulatory requirements in order to access new capabilities of CROs, focusing on core competencies and variable costs. As most of the global CROs established their operations...